Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
8.06
0.48 (6.33%)
At close: Jun 06, 2025, 3:59 PM
8.14
0.93%
After-hours: Jun 06, 2025, 05:58 PM EDT

Intellia Therapeutics Statistics

Share Statistics

Intellia Therapeutics has 103.58M shares outstanding. The number of shares has increased by 7.3% in one year.

103.58M
7.3%
1.64%
98.29%
n/a
560
0.01%

Short Selling Information

The latest short interest is 30.7M, so 29.64% of the outstanding shares have been sold short.

30.7M
29.64%
33.74%
8.69

Valuation Ratios

The PE ratio is -2.22 and the forward PE ratio is -1.94. Intellia Therapeutics's PEG ratio is 0.71.

-2.22
-1.94
19.91
0.4
1.32
-3.25
0.71
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Intellia Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.24.

5.77
5.77
0.24
-0.4
-0.59
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$143,615.38
$-1,287,893.3
403
0.05
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -64.54% in the last 52 weeks. The beta is 2.13, so Intellia Therapeutics's price volatility has been higher than the market average.

2.13
-64.54%
7.93
13.05
49.11
3,998,796

Income Statement

In the last 12 months, Intellia Therapeutics had revenue of 57.88M and earned -519.02M in profits. Earnings per share was -5.25.

57.88M
47.59M
-534.26M
-519.02M
-523.98M
-534.26M
-5.25
Full Income Statement

Balance Sheet

The company has 189.18M in cash and 210.2M in debt, giving a net cash position of -21.02M.

189.18M
210.2M
-21.02M
-2.18B
986.16M
438.8M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -348.88M and capital expenditures -5.78M, giving a free cash flow of -354.66M.

-348.88M
-5.78M
-354.66M
-3.59
Full Cash Flow Statement

Margins

Gross margin is 82.23%, with operating and profit margins of -923.1% and -896.77%.

82.23%
-923.1%
-896.77%
-896.77%
-905.33%
-923.1%
-612.78%

Dividends & Yields

NTLA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for NTLA is $40.5, which is 402.5% higher than the current price. The consensus rating is "Buy".

$40.5
402.5%
Buy
20
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-2.27
2